Randomized, Double-Blind, multicenter, trial to assess the effect of high and Low doses of ZD4522 on progression of Carotid Artery Atheroma in moderately Hypercholesterolemic subjects with Asymptomatic Carotid Stenosis after 24 months of dosing.

Study identifier:D3560C00004

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Randomized, Double-Blind, multicenter, trial to assess the effect of high and Low doses of ZD4522 on progression of Carotid Artery Atheroma in moderately Hypercholesterolemic subjects with Asymptomatic Carotid Stenosis after 24 months of dosing.

Medical condition

hypercholesterolaemia

Phase

Phase 3

Healthy volunteers

-

Study drug

-

Sex

-

Actual Enrollment

-

Study type

Interventional

Age

-

Date

Study Start Date: 01 Jan 2000
Primary Completion Date: -
Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Feb 2015 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria